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Abstract
Midbrain dopamine neurons project to numerous targets throughout the brain to modulate various behaviors and
brain states. Within this small population of neurons exists significant heterogeneity based on physiology,
circuitry, and disease susceptibility. Recent studies have shown that dopamine neurons can be subdivided based
on gene expression; however, the extent to which genetic markers represent functionally relevant dopaminergic
subpopulations has not been fully explored. Here we performed single-cell RNA-sequencing of mouse dopamine
neurons and validated studies showing that Neurod6 and Grp are selective markers for dopaminergic subpopu-
lations. Using a combination of multiplex fluorescent in situ hybridization, retrograde labeling, and electrophys-
iology in mice of both sexes, we defined the anatomy, projection targets, physiological properties, and disease
vulnerability of dopamine neurons based on Grp and/or Neurod6 expression. We found that the combinatorial
expression of Grp and Neurod6 defines dopaminergic subpopulations with unique features. Grp/Neurod6
dopamine neurons reside in the ventromedial VTA, send projections to the medial shell of the nucleus accumbens,
and have noncanonical physiological properties. Grp/Neurod6- dopamine neurons are found in the VTA as well
as in the ventromedial portion of the SNc, where they project selectively to the dorsomedial striatum. Grp-/
Neurod6 dopamine neurons represent a smaller VTA subpopulation, which is preferentially spared in a 6-OHDA
model of Parkinson’s disease. Together, our work provides detailed characterization of Neurod6 and Grp
expression in the midbrain and generates new insights into how these markers define functionally relevant
dopaminergic subpopulations.
Key words: Dopamine Neurons; Grp; Neurod6; Retrograde Tracing; Single-Cell RNA-Sequencing; VTA;
Cellular Heterogeneity
Significance Statement
Recent single-cell gene profiling studies have uncovered new subpopulations of midbrain dopamine (DA)
neurons defined by their specific patterns of gene expression. How these genetically defined cell types map
onto known dopaminergic circuits and functionally defined cell types is unknown. This study elucidates the
anatomy, circuitry, physiological properties, and disease susceptibility of midbrain DA neuron subpopula-
tions defined by their expression of two genetic markers. This work not only advances our understanding
of the dopaminergic system by providing new information about the properties of specific dopamine neuron
subpopulations, it also demonstrates that unbiased genetic classification of neurons can reveal functionally
relevant cell types.
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Introduction
Midbrain dopamine (DA) neurons of the substantia nigra
pars compacta (SNc) and ventral tegmental area (VTA)
make widespread projections throughout the brain and
modulate a host of behaviors from motor function to
reward learning to cognition (Björklund and Dunnett,
2007). Although they represent only0.03% of neurons in
the mouse brain, DA neurons are heterogeneous, as they
vary significantly in their circuitry (Lammel et al., 2011;
Watabe-Uchida et al., 2012; Beier et al., 2015; Menegas
et al., 2015), physiology (Lammel et al., 2008; Lerner et al.,
2015), gene expression (Poulin et al., 2014; La Manno
et al., 2016), and response to disease (Damier et al., 1999;
Di Salvio et al., 2010a; Blesa and Przedborski, 2014;
Brichta and Greengard, 2014). VTA DA neurons are par-
ticularly diverse, comprising multiple subcircuits that
project to different brain regions and have distinct elec-
trophysiological properties according to their projection
target (Lammel et al., 2008; Margolis et al., 2008; Morales
and Margolis, 2017). Depending on their connectivity, VTA
neurons can also mediate opposing behaviors, such as
reward and aversion (Lammel et al., 2012), necessitating
tools that can parse this functional heterogeneity to allow
selective manipulation of specific VTA subpopulations
(Poulin et al., 2016; Vogt Weisenhorn et al., 2016). Build-
ing on prior studies that identified genetic differences
between SNc and VTA neurons (Grimm et al., 2004;
Chung et al., 2005; Greene et al., 2005; Di Salvio et al.,
2010b), recent single-cell gene profiling studies have un-
covered further genetic heterogeneity in the DA system,
including several subtypes of VTA neurons (Poulin et al.,
2014; La Manno et al., 2016). However, it is currently
unknown how these genetically defined classes of DA neu-
rons map onto subtypes defined by their circuitry and phys-
iology.
A notable feature of dopaminergic subpopulations is
their differential vulnerability to disease. For example, in
the neurodegenerative disorder Parkinson’s disease (PD),
SNc DA neurons degenerate earlier and to a greater degree
than VTA DA neurons (Damier et al., 1999; Alberico et al.,
2015). The reason for this selective vulnerability is not well
understood, although current hypotheses point to differ-
ences in the expression of ion channels and metabolic
proteins between SNc and VTA neurons (Chung et al.,
2005; Greene et al., 2005; Liss et al., 2005; Chan et al.,
2007; Brichta and Greengard, 2014; Liu et al., 2014).
Despite the relative sparing of the VTA compared to the
SNc, 40%–77% of VTA DA neurons still degenerate (Al-
berico et al., 2015) and the molecular features that define
susceptible versus spared VTA neurons are unknown.
Here our goal was to define dopaminergic subpopula-
tions based on gene expression and determine how these
populations map onto DA subtypes defined by physiology
and circuitry. To do this, we analyzed DA neuron popula-
tions marked by two genes, Grp and Neurod6, that we
identified by single-cell RNA-sequencing (RNA-seq), and
which have previously been reported to mark subpopula-
tions of VTA DA neurons (Chung et al., 2005; Greene et al.,
2005; Poulin et al., 2014; La Manno et al., 2016; Viereckel
et al., 2016; Khan et al., 2017). With a combination of
anatomy, retrograde tracing, and physiology, we show
that these genes define overlapping yet distinct DA neu-
ron populations. We further demonstrate that the combi-
natorial expression of these two genes influences
susceptibility to degeneration in a 6-OHDA mouse model of
PD. Together, our findings further our understanding of do-
paminergic cell type diversity and validate genetic ap-
proaches for defining functional cell types in the brain.
Materials and Methods
Mice
Animal procedures were conducted in accordance with
protocols approved by the University of California, Berke-
ley Institutional Animal Care and Use Committee (IACUC)
and Office of Laboratory Animal Care (OLAC).
For single-cell RNA-seq experiments, DATIRESCre mice
(Bäckman et al., 2006; Jackson Laboratory strain #006660,
RGD_12905031) were crossed and maintained with the
Ai9 tdTomato Cre-reporter line (Madisen et al., 2010;
Jackson Laboratory strain #007909). For physiology ex-
periments, NEX-Cre mice were obtained from Dr. Klaus-
Armin Nave (Goebbels et al., 2006) and crossed with the
Ai9 mouse line. C57BL/6J mice were used for retrograde
bead injections. The ages, sexes, and numbers of mice
used are indicated for each experiment in the results and
figure legends.
Single-cell RNA-seq
Postnatal day (P)26 to 34 male and female DATIRESCre;
Ai9 mice were briefly anesthetized with isoflurane and
decapitated, and brains were removed and placed in
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ice-cold, oxygenated artificial CSF (ACSF; NaCl 125 mM,
NaHCO3 25 mM, NaH2PO4 1.25 mM, KCl 2.5 M, MgCl2 1
mM, CaCl2 2 mM, glucose 25 mM). The brain was cut
coronally into 275-m sections on a vibratome (Leica
VT1000 S) in oxygenated ice-cold choline cutting solution
(choline chloride 100 mM, NaHCO3 25 mM, NaH2PO4 1.25
mM, KCl 2.5 mM, MgCl2 7 mM, CaCl2 0.5 mM, glucose
25 mM, sodium ascorbate 11.6 mM, sodium pyruvate 3.1
mM). Midbrain sections were incubated for 15 min in
ACSF at 34˚C. Midbrain (including the hypothalamus) was
dissected in ACSF using forceps under a dissection mi-
croscope. Midbrain sections were incubated in 10 ml
oxygenated papain solution (papain 10 U/ml (Worthington
#LK003176) in ACSF with 10 mM HEPES, 10 U/ml DNase,
2.5 mM EDTA, 2.5 mM cysteine, 1 mM kynurenic acid, and
5 mM CaCl2) for 25 min at 34˚C. Following papain digestion,
tissue was placed into 9 ml oxygenated STOP-ovomucoid
inhibitor solution [1 ml/mg ovomucoid (Worthington
#LK003182) in HEPES-ACSF, 10 U/ml DNase, 1 mM
kynurenic acid, and 5 mM CaCl2] and bubbled gently at
34˚C. 8 ml of the supernatant solution was removed, and
the tissue was triturated serially in the remaining 2 ml of
solution with polished 3-, 2-, and 1-mm glass pipettes to
create a single-cell suspension. The 2 ml single-cell sus-
pension was spun down in a 20% Percoll solution (600 l
Percoll (Sigma #P4937) in 2.4 ml STOP-ovomucoid solu-
tion at 430  g for 6 min at room temperature (RT). The
supernatant was aspirated, leaving50 l of solution and
the cell pellet. The pellet was resuspended in 1 ml
HEPES-ACSF with 1 mM kynurenic acid and 5% FBS (Life
Technologies #16140063).
This single-cell suspension was sorted on a BD Influx
cell sorter in the Flow Cytometry Facility at UC Berkeley.
Cells were gated for PI-/tdTomato and sorted into a PCR
tube. Based on the number of neurons sorted and cell
viability count, neurons were brought to 200,000 neu-
rons/ml. Neurons were then put into a large Fluidigm C1
chip, and each of the 96 wells was visually inspected to
verify cell presence, cell health, and tdTomato expression.
Wells containing cell doublets were excluded from further
processing.
Cells went through single-cell mRNA extraction using
the Fluidigm C1 system in the Functional Genomics Lab-
oratory at UC Berkeley. Single-cell cDNA was removed
and measured via Qubit. Any cell that gave 0.3 g/ml of
cDNA was removed due to likely low quality. cDNA from
single cells that passed the initial quality check was di-
luted to 0.3 g/ml. 379 single-neuron cDNA extracts were
library prepped using the Nextera DNA library prep pro-
tocol (Illumina #FC-121-1012). The cDNA was then se-
quenced on a HiSeq 2500 in the Vincent J. Coates
Genomics Sequencing Laboratory at UC Berkeley.
Single-cell RNA-seq preprocessing
Reads were aligned to the GRCm38.3 (mm10, patch
release 3) mouse genome assembly with Tophat2 (v.
2.1.1; Kim et al., 2013), and low-quality reads were re-
moved with Trimmomatic (v. 0.3.2; Bolger et al., 2014).
Gene expression was quantified using featureCounts (v.
1.5.0-p3; Liao et al., 2014) and RefSeq transcript annota-
tion. Reads that aligned to more than one gene as well as
chimeric fragments were excluded. We used a quality
control (QC) pipeline that computes an extensive set of
quality metrics, relying in part on FastQC (v. 0.3.2) and the
Picard tools (v. 2.5.0 with samtools 1.3.1) as done previ-
ously (Fletcher et al., 2017). We used the Bioconductor
package scone (https://bioconductor.org/packages/scone; v.
0.99.6) to perform data-adaptive cell and gene filtering.
This yielded the following exclusion criteria: any cell with
fewer than 500,000 aligned reads or a percentage of
aligned reads below 85%. In addition, we filtered out cells
with large dropout rates, as defined by the “false-negative
curves” of scone. This procedure resulted in a total of 232
retained cells (out of 379). Finally, we retained only those
genes having at least 10 reads in at least 10 cells (10,983
genes).
Single-cell RNA-seq statistical analysis
We performed and assessed several normalization
schemes using scone (Cole et al., 2017) and selected full-
quantile normalization (Bolstad et al., 2003; Bullard et al.,
2010). We then applied principal component analysis on
the normalized data and retained the first 50 principal
components, which explained 41% of the variance. Clus-
ter analysis was performed on the first 50 principal com-
ponents using the RSEC method (Risso et al., 2018b)
implemented in the Bioconductor package clusterExperi-
ment (https://bioconductor.org/packages/clusterExperi-
ment; v. 1.0.0), as previously described (Fletcher et al.,
2017). We used RSEC with the following specific param-
eters: alphas  0.3, minSizes  5, combineProportions 
0.5; all other parameters were left at their default values.
RSEC found 9 stable clusters. We used limma (v. 3.30.13)
with voom correction weights (Law et al., 2014), as imple-
mented in the clusterExperiment function getBestFeature,
to find marker genes for each cluster. To visualize the
clustering results, we applied ZINB-WaVE (Risso et al.,
2018a; with K 10) for dimensionality reduction, followed
by t-distributed stochastic neighbor embedding (t-SNE;
perplexity parameter set to 20; van der Maaten and Hin-
ton, 2008).
Accession number and code accessibility
The accession number for the RNA-seq data reported
in this paper is GEO: GSE115070. The computer code for
the single-cell RNA-seq analysis is available at https://
github.com/drisso/striatum. This code was run on an Ap-
ple Mac computer with macOS Sierra 10.12.4 operating
system.
Fluorescent in situ hybridization
To visualize mRNA we used the RNAScope fluorescent
in situ hybridization (FISH) method (ACDBio). Fresh-frozen
tissue was processed as per RNAScope instructions.
Briefly, mouse brain tissue from male and female mice
aged P21–P120 was fresh-frozen in OCT on dry ice and
stored at least overnight at –80˚C. Tissue was then cut on
a cryostat (Leica Microm HM550) into 12 m sections and
mounted onto slides. Slides were fixed in 4% PFA in 1
PBS for 15 min. Slides were dehydrated using 5 min
incubations in 50%, 70%, and twice with 100% ethanol.
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Slides were incubated with RNAScope Protease IV (ACD-
Bio #322340) at RT for 30 min and washed with 1 PBS.
FISH was then performed using the RNAScope Multiplex
Fluorescent assay (ACDBio #320850) per the manufactur-
er’s instructions and protocols. Following FISH, slides
were coverslipped using ProLong Gold Antifade mounting
media (Invitrogen #P36934). RNAScope probes used:
mM-Neurod6 (#444851), mM-Grp (#317861), mM-Th
(#317621), mM-Slc6a3 (#315441), mM-Lypd1 (#447081).
Microscopy and image analysis
Two confocal microscopes were used to take Z-stack
images of FISH-labeled or immunostained sections: an
Olympus FV1000 with a 20 Nikon objective and a Zeiss
LSM 710 AxioObserver with Zeiss 10, 20, and 63
objectives housed in the Molecular Imaging Center at UC
Berkeley. Images were analyzed using the Fiji image anal-
ysis toolbox. Cells were considered positive for Neurod6,
Grp, or Lypd1 if they contained three fluorescent puncta
within the boundary created by a cell marker: Slc6a3
(DAT), Th, or DAPI.
Retrobead and virus intracranial injections
P14–P18 wild-type male and female mice were used for
retrograde labeling experiments. Green Retrobeads IX
(Lumaflour #G180) were diluted 1:7 in sterile 1 PBS
unless otherwise noted. Beads were bilaterally injected
using a pulled glass pipette. The following coordinates
from bregma and bead volumes were used to target each
projection site: dorsomedial striatum (DMS; M/L 1.35
mm, A/P 0.75 mm, D/V –2.60 mm, 400 nl beads), dor-
solateral striatum (DLS; M/L 2.15 mm, A/P 0.70 mm,
D/V –2.50 mm, 400 nl beads), nucleus accumbens (NAc)
medial shell (M/L 0.75 mm, A/P 1.20 mm, D/V –4.15
mm, 300 nl beads), NAc core (M/L /1.2 mm, A/P 1.10
mm, D/V –4.05 mm, 300 nl beads), NAc lateral shell (M/L
1.75 mm, A/P 1.05 mm, D/V –3.95 mm, 300 nl beads),
basolateral amygdala (M/L2.65 mm, A/P –1.05 mm, D/V
–4.40 mm, 120 nl beads at 1:3 dilution), medial prefrontal
cortex (four injections per hemisphere at two different
depths per injection: M/L 0.35 mm, A/P 1.50 mm,
1.65 mm, 1.80 mm, and 1.95 mm, D/V –2.00 mm
and –1.40 mm, 400 nl total per hemisphere), and lateral
septum (M/L 0.45 mm, A/P 0.40 mm, D/V –2.70 mm,
300 nl beads).
To allow for sufficient DA neuron labeling, mice were
sacrificed at various time points following injection: 7 d for
the DMS and DLS, 21 d for the prefrontal cortex, and 14
d for the NAc (medial shell, core, and lateral shell), lateral
septum and amygdala. Brains were harvested and cut to
separate the injection site and midbrain. The midbrain
was frozen for cryostat sectioning as described above for
FISH. The brain region containing the injection site was
incubated in 4% PFA overnight at 4˚C, then cryoprotected
in 30% sucrose in 1 PB until the tissue sank. Injection site
tissue was sectioned on a freezing microtome, mounted
with Vectashield hardset mounting media with DAPI (Vector
laboratories #H-1500), and analyzed for bead expression at
the injection site. Brains with correctly targeted injection
sites and minimal off-target bead expression were chosen
for analysis.
To selectively label NEX-Cre–expressing neurons in the
VTA, we unilaterally injected 800 nl of a Cre-dependent
tdTomato virus (AAV1.CAG.Flex.tdTomato.WPRE.bGH,
Penn Vector Core #AV-1-ALL864) into heterozygous NEX-
Cre mice at P16. To target the VTA, we used the following
coordinates from bregma: M/L 0.25 mm, A/P –2.9 mm,
D/V –4.45 mm.
Immunohistochemistry
Immunohistochemistry was performed as described
previously (Bateup et al., 2013). The following antibodies
were used: tyrosine hydroxylase (TH, ImmunoStar #22941,
RRID:AB_572268), Alexa Fluor 488 goat anti-mouse sec-
ondary (Thermo Fisher Scientific #A-11001, RRID:
AB_2534069), Alexa Fluor 633 goat anti-mouse secondary
(Thermo Fisher Scientific #A-21050, RRID:AB_2535718),
streptavidin Alexa Fluor 488 conjugate (Thermo Fisher Sci-
entific #S32354, RRID:AB_2315383), and streptavidin Alexa
Fluor 633 conjugate (Thermo Fisher Scientific #S21375,
RRID:AB_2313500).
Electrophysiology
275-m-thick coronal midbrain slices were prepared
from P56–P105 NEX-Cre;Ai9 or DATIRESCre;Ai9 mice of
both sexes on a vibratome (Leica VT1000 S) in ice-cold
high Mg2 ACSF containing, in mM: 85 NaCl, 25 NaHCO3,
2.5 KCl, 1.25 NaH2PO4, 0.5 CaCl2, 7 MgCl2, 10 glucose,
and 65 sucrose. Slices were recovered for 15 min at 34°C
followed by 50 min at RT in ACSF containing, in mM: 130
NaCl, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 2 CaCl2, 2
MgCl2, and 10 glucose. NEX-Cre
 VTA neurons were iden-
tified by tdTomato fluorescence in NEX-Cre;Ai9 mice. SNc
neurons were defined either by the presence of green
retrobeads injected into the dorsolateral striatum in NEX-
Cre;Ai9 mice or by tdTomato fluorescence and anatomic
location in DATIRESCre;Ai9 mice. For whole-cell record-
ings, 2.5–6 m glass pipettes were filled with a
potassium-based internal solution containing, in mM: 135
KMeSO3, 5 KCl, 5 HEPES, 4 Mg-ATP, 0.3 Na-GTP, 10
phospho-creatine, 1 EGTA, and 4 mg/ml neurobiotin
(Vector laboratories #SP-1120). Recordings were ob-
tained using a MultiClamp 700B amplifier (Molecular De-
vices) and ScanImage software. Passive membrane
properties were recorded in voltage clamp with the mem-
brane held at –70 mV. Spontaneous action potentials
were recorded in current clamp. In current clamp, 500 ms
steps of negative current were delivered (–25 to –150 pA)
to hyperpolarize the membrane to approximately –100
mV. During the steps, current was injected to maintain the
baseline membrane potential at –70 mV. All recordings
were performed at RT in the presence of synaptic block-
ers (NBQX 10 M, CPP 10 M, picrotoxin 50 M, final
concentration). Data were analyzed in Igor (Wavemetrics)
using custom scripts.
6-OHDA injection
6-hydroxydopamine (6-OHDA; 6-hydroxydopamine hy-
drobromide with ascorbic acid: Sigma-Aldrich #H116-
5MG) injections were made into the medial forebrain
bundle of P120 female mice as previously described
(Thiele et al., 2012). 30 min before 6-OHDA injection, a
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solution containing 0.5 mg/ml pargyline (Sigma Aldrich
#P8013) and 2.5 mg/ml desipramine hydrochloride (Tocris
#3067) was injected i.p. at a dose of 5 mg/kg pargyline
and 25 mg/kg desipramine. 200 nl of freshly prepared 15
mg/ml 6-OHDA in sterile saline  0.02% ascorbic acid
were injected into the medial forebrain bundle (MFB, co-
ordinates from bregma: M/L  1.2 mm, A/P 1.2 mm, D/V
–4.90 mm). Adult female wild-type mice were used as
younger mice and male mice showed poor recovery fol-
lowing injection. 250–350 l of meloxicam (5–10 mg/kg
dose) was injected subcutaneously as an analgesic.
Mice were monitored daily following the injection to
ensure recovery. Kitten Milk Replacement (Santa Cruz
#sc-362120) was fed to mice daily for up to 2 wk following
the injection to aid recovery and meloxicam was injected
subcutaneously to alleviate pain if necessary. Motor func-
tion was assessed using the cylinder test each week
following the injection (see below). 4 wk following 6-OHDA
injection, mice were quickly anesthetized using isoflurane
and decapitated, and their brains were fresh-frozen as
described above for FISH.
Cylinder test
To test the severity of Parkinsonian-like symptoms fol-
lowing unilateral 6-OHDA injection, we used the cylinder
test to score limb use asymmetry. Mice were habituated
to the behavior room for a minimum of 30 min during their
dark cycle under red light illumination. Mice were placed
into a clear plastic cylinder 12 cm in diameter and 20 cm
in height. The cylinder was placed next to two mirrors to
visualize paw use. The mouse was both video recorded
and observed by the experimenter while it was allowed to
move around freely in the cylinder for 10 min. Full 360°
ipsiversive and contraversive rotations (relative to the
6-OHDA injection side) were counted. Forelimb asymme-
try was measured by counting the number of times the
ipsilateral paw, contralateral paw, or both paws were used
for support when the mouse reared against the wall of the
cylinder. The percentage of ipsilateral or contralateral paw
use was calculated based on total rears (e.g., ipsilateral
paw touches/ipsilateral  contralateral  both paw
touches). A greater number of ipsiversive turns and ipsi-
lateral paw use indicates a successful 6-OHDA injection
and unilateral Parkinsonian-like symptoms.
Experimental design and statistical analysis
A one-way ANOVA was used to compare the means of
three or more groups. Post hoc pairwise comparisons
were made using either Bonferroni’s or Tukey’s multiple
comparisons tests. Unpaired or paired two-tailed t tests
were used to compare the means of two groups. A paired,
one-way ANOVA with Dunnett’s multiple comparisons
post hoc test was used to compare DA neuron subpopu-
lations to the entire VTA DA population for the 6-OHDA
experiments. Data are reported as the mean  SEM.
Superscript letters listed with p-values correspond to the
statistical tests shown in Table 1. p-values were corrected
for multiple comparisons.
Results
Single-cell RNA-seq of midbrain dopamine neurons
To define subclasses of DA neurons in an unbiased
way, we performed single-cell RNA sequencing of DA
neurons from P26–P34 male and female mice in which
dopamine transporter (DAT)-expressing neurons were la-
beled with a tdTomato reporter (DATIRESCre;Ai9, Fig.
1-1A). A bioinformatic and statistical workflow revealed
nine clusters of DA neurons based on differential gene
expression (Fig. 1-1B–E and Table 1-1). We identified
markers for each cluster and validated eight of the nine
clusters. Two of the clusters corresponded to DA sub-
populations in the hypothalamus, four defined subclasses
of VTA neurons, and two corresponded to the SNc (Fig.
1-1F). These populations are consistent with recent
single-cell DA neuron profiling studies (Poulin et al., 2014;
La Manno et al., 2016; Romanov et al., 2017).
Grp and Neurod6 define anatomically overlapping
but distinct midbrain subpopulations
Consistent with prior studies (Poulin et al., 2014; La
Manno et al., 2016), we identified a cell cluster that
showed relatively high and selective expression of Grp,
Neurod6, and Gpr83 (cluster #8, Fig. 1-1C). Given recent
interest in Neurod6 and Grp as markers that label ventro-
medial VTA DA neurons (La Manno et al., 2016; Viereckel
et al., 2016; Khan et al., 2017), we chose to quantitatively
analyze their expression patterns in the midbrain and
examine the extent of their overlap. Using multiplex FISH,
we found that in adult mice, Grp-expressing neurons
represented 29.9%  0.5% of the total midbrain DA
neuron population (1804/6407 neurons from 8 mice) and
35.9%  0.4% of DA neurons in the VTA (1570/4377
neurons from 8 mice; Fig. 1A–D). 97.4%  0.7% of Grp
cells in the midbrain were dopaminergic, defined by co-
expression of tyrosine hydroxylase (Th) mRNA (1780/1822
cells from 4 mice). Grp DA neurons were found in all
subregions of the VTA but were enriched in the ventro-
medial portions of the VTA, the interfascicular nucleus (IF),
and paranigral/parainterfascicular nuclei (PN/PIF; p 
0.0001,a one-way ANOVA with Tukey’s post hoc test, Fig.
1E). Notably, while Grp was previously identified as a VTA
marker (Chung et al., 2005; Greene et al., 2005; Viereckel
et al., 2016), we also found Grp-expressing DA neurons in
the ventromedial portion of the SNc (22.7% 1.8% of DA
neurons in this region, Fig. 1A–F).
Neurod6 expression defined a more restricted DA pop-
ulation, accounting for 26.8%  0.5% of VTA DA neurons
(1172/4377 neurons from 8 mice), with the highest density
of Neurod6 DA neurons in the ventromedial IF and PN/
PIF regions (p  0.0001,b one-way ANOVA with Tukey’s
post hoc test, Fig. 1E). In contrast to Grp, Neurod6 mRNA
was not expressed in the SNc (Fig. 1A–F). 93.1%  0.6%
of Neurod6 VTA neurons were dopaminergic (948/1016
cells from 4 mice). Consistent with our RNA-seq data, we
found that most, but not all, Neurod6 DA neurons coex-
pressed Grp (77.5% 0.8%, 909/1172 cells from 8 mice).
Broken down by subregion, the majority of Neurod6 DA
neurons in the IF and PN/PIF coexpressed Grp; however,
a third of Neurod6 DA neurons in the PBP did not have
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Table 1. Statistical analysis
Location Data structure Type of test CI/power P value Comparison
a Normally distributed One-way ANOVA 0.97 0.0001 Grp expression in midbrain subregions
Normally distributed Tukey’s post hoc 6.508 to 17.74 0.0001 Grp IF vs. PN/PIF
Normally distributed Tukey’s post hoc 34.77 to 46 0.0001 Grp IF vs. PBP
Normally distributed Tukey’s post hoc 35.1 to 46.33 0.0001 Grp IF vs. SNc-V
Normally distributed Tukey’s post hoc 57.26 to 68.49 0.0001 Grp IF vs. SNc-D
Normally distributed Tukey’s post hoc 22.65 to 33.88 0.0001 Grp PN/PIF vs. PBP
Normally distributed Tukey’s post hoc 22.97 to 34.2 0.0001 Grp PN/PIF vs. SNc-V
Normally distributed Tukey’s post hoc 45.13 to 56.37 0.0001 Grp PN/PIF vs. SNc-D
Normally distributed Tukey’s post hoc –5.292 to 5.942 0.9998 Grp PBP vs. SNc-V
Normally distributed Tukey’s post hoc 16.87 to 28.1 0.0001 Grp PBP vs. SNc-D
Normally distributed Tukey’s post hoc 16.55 to 27.78 0.0001 Grp SNc-V vs. SNcD
b Normally distributed One-way ANOVA 0.96 0.0001 Neurod6 expression in midbrain
subregions
Normally distributed Tukey’s post hoc –0.4177 to 9.918 0.0842 Neurod6 IF vs. PN/PIF
Normally distributed Tukey’s post hoc 16.28 to 26.62 0.0001 Neurod6 IF vs. PBP
Normally distributed Tukey’s post hoc 34.69 to 45.03 0.0001 Neurod6 IF vs. SNc-V
Normally distributed Tukey’s post hoc 35.82 to 46.16 0.0001 Neurod6 IF vs. SNc-D
Normally distributed Tukey’s post hoc 11.53 to 21.87 0.0001 Neurod6 PN/PIF vs.
Normally distributed Tukey’s post hoc PBP
Normally distributed Tukey’s post hoc 29.94 to 40.28 0.0001 Neurod6 PN/PIF vs. SNc-V
Normally distributed Tukey’s post hoc 31.07 to 41.41 0.0001 Neurod6 PN/PIF vs. SNc-D
Normally distributed Tukey’s post hoc 13.24 to 23.58 0.0001 Neurod6 PBP vs. SNc-V
Normally distributed Tukey’s post hoc 14.37 to 24.71 0.0001 Neurod6 PBP vs. SNc-D
Normally distributed Tukey’s post hoc –4.043 to 6.293 0.9699 Neurod6 SNc-V vs. SNc-D
c Normally distributed One-way ANOVA 0.522 0.036 Grp expression by age
Normally distributed Tukey’s post hoc –1.112 to 2.462 0.5636 Grp 2 wk vs. 8 wk
Normally distributed Tukey’s post hoc –3.087 to 0.4872 0.1603 Grp 2 wk vs. 16 wk
Normally distributed Tukey’s post hoc –3.762 to –
0.1878
0.0316 Grp 8 wk vs. 16 wk
d Normally distributed One-way ANOVA 0.56 0.0236 Neurod6 expression by age
Normally distributed Tukey’s post hoc –2.859 to 1.109 0.4655 Neurod6 2 wk vs. 8 wk
Normally distributed Tukey’s post hoc –4.384 to –
0.4162
0.0201 Neurod6 2 wk vs. 16 wk
Normally distributed Tukey’s post hoc –3.509 to 0.4588 0.1351 Neurod6 8 wk vs. 16 wk
e Normally distributed Unpaired t test –7.68 to 3.147 0.3728 Grp IF M vs. F
f Normally distributed Unpaired t test –12.78 to 0.4155 0.0634 Grp PN/PIF M vs. F
g Normally distributed Unpaired t test –1.924 to 4.89 0.3549 Grp PBP M vs. F
h Normally distributed Unpaired t test –7.321 to 5.188 0.7119 Grp SNCv M vs. F
i Normally distributed Unpaired t test –0.6657 to 1.199 0.5383 Grp SNCd M vs. F
j Normally distributed Unpaired t test –13.48 to 4.412 0.2852 Neurod6 IF M vs. F
k Normally distributed Unpaired t test –8.615 to 3.682 0.3924 Neurod6 PN/PIF M vs. F
l Normally distributed Unpaired t test –1.028 to 2.095 0.4642 Neurod6 PBP M vs. F
m Normally distributed Unpaired t test –2.251 to 0.1514 0.0801 Neurod6 SNCv M vs. F
n Negative binomial Likelihood ratio test n/a 0.5113 Neurod6 M vs. F RNASeq data
o Negative binomial Likelihood ratio test n/a 0.6835 Grp M vs. F RNASeq data
p Normally distributed Unpaired t test –9.156 to –1.532 0.0075 Vm – SNc vs. NEXCre
q Normally distributed Unpaired t test –1222 to –729.4 0.0001 Rm – SNc vs. NEXCre
r Normally distributed Unpaired t test 23.67 to 43.99 0.0001 Cm – SNc vs. NEXCre
s Normally distributed Unpaired t test 11.3 to 21.88 0.0001 AP height – SNc vs. NEX-Cre
t Normally distributed Unpaired t test 3.372 to 9.524 0.0002 AHP – SNc vs. NEXCre
u Normally distributed Unpaired t test 6.564 to 10.49 0.0001 Sag – SNc vs. NEXCre
v Normally distributed Unpaired t test 4.295 to 7.773 0.0001 Rebound – SNc vs. NEX-Cre
w Normally distributed One-way ANOVA 0.85 0.0002 Cylinder test
Normally distributed Tukey’s post hoc 6.33 to 55.07 0.0163 Saline vs. 6-OHDA paw
Normally distributed Tukey’s post hoc –55.27 to –6.53 0.0157 Saline vs. both paws
Normally distributed Tukey’s post hoc –85.97 to –37.23 0.0002 6-OHDA vs. both paws
x Normally distributed Paired one-way ANOVA 0.96 0.0001 Cell population survival
Normally distributed Dunnett’s post hoc –69.31 to –34.69 0.0022 All TH vs. Grp-/ Neurod6
Normally distributed Dunnett’s post hoc –6.01 to 15.16 0.3169 All TH vs. Grp/ Neurod6
Normally distributed Dunnett’s post hoc 2.07 to 15.78 0.0246 All TH vs. Grp/ Neurod6-
Normally distributed Dunnett’s post hoc 0.6149 to 15.14 0.0403 All TH vs. Lypd1/Neurod6-
y Normally distributed Paired t test –3.593 to 3.043 0.8091 Lypd1/Neurod6 saline vs. 6-OHDA
New Research 6 of 16
May/June 2018, 5(3) e0152-18.2018 eNeuro.org
Figure 1. Anatomic analysis of Grp and Neurod6-expressing DA neurons in the midbrain. A, Confocal images of multiplex fluorescent
in situ hybridization using probes against Grp (left), Neurod6 (middle), and tyrosine hydroxylase (Th, right) mRNA. Inset boxes show
higher-magnification images of the boxed regions. B, Schematic showing the location of Grp (blue), Neurod6 (red), and
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detectable expression of Grp (Fig. 1F). Grp-expressing
but Neurod6-lacking DA neurons were found throughout
the VTA, and nearly all of the Grp DA neurons in the SNc
were lacking Neurod6 (Fig. 1F).
Together, these data show that Grp is expressed in a
subpopulation of midbrain DA neurons spanning the VTA
and ventromedial portion of the SNc. Neurod6 is ex-
pressed in a more restricted midbrain population, defining
a subgroup of the Grp DA population, which is located
exclusively in the VTA. In addition, there is a small subset
of VTA DA neurons that express Neurod6 but not Grp.
To determine if these cell populations were present
throughout development, we assessed Grp and Neurod6
expression at multiple ages. We found that while there
were subtle increases in the percentages of Grp VTA DA
neurons from 8 to 16 wk (p  0.036,c one-way ANOVA with
Tukey’s post hoc test, Fig. 1G) and Neurod6 VTA DA
neurons from 2 to 16 wk (p  0.024,d one-way ANOVA
with Tukey’s post hoc test, Fig. 1H), the proportions of DA
neurons expressing these markers were largely stable
from 2 wk postnatal through adulthood (P14–P112). We
also investigated whether these cell populations were
similar between sexes. We found that the Grp- and
Neurod6-expressing DA subpopulations were present in
male and female mice in similar proportions throughout
VTA and SNc subregions (see statistics worksheet for
unpaired t test p values,e–m Fig. 1I,J). Furthermore, in the
RNA-seq data, we found no significant differences in
expression levels of Grp or Neurod6 between males and
females (log2-fold-change of 1.70 for Neurod6, p  0.51n
and 0.94 for Grp, p  0.68o in males versus females,
likelihood ratio test). These data demonstrate that the
Grp and Neurod6 DA neuron populations are present in
both sexes and stable over time.
Grp and Neurod6-expressing neurons project to the
nucleus accumbens medial shell
VTA DA neurons comprise multiple subcircuits, which
send projections to different brain regions with distinct
functional consequences (Roeper, 2013). To determine if
the Grp and Neurod6 DA populations have specific pro-
jection targets, we combined retrograde labeling from
eight primary DA neuron projection sites with Grp and
Neurod6 FISH (Fig. 2A and Fig. 2-1A). We found that of
the DA neurons projecting to the medial shell of the
nucleus accumbens (NAc), 75.0%  1.1% were Grp-
positive and 70.4%  2.5% were Neurod6-positive, indi-
cating that these markers were expressed in the majority
of medial shell-projecting DA neurons (Fig. 2B,C,F,H).
Grp and Neurod6 DA neurons also projected to the
NAc core and lateral shell but represented a smaller frac-
tion of the neurons projecting to these regions compared
to the medial shell (Fig. 2F,H). When quantified as a percent-
age of the total marker-positive bead-labeled DA neurons
across all injection sites, the NAc medial shell was the
primary target region for both Grp and Neurod6 DA
neurons (Fig. 2G,I). Together, these findings indicate a
strong mesoaccumbens projection from Neurod6 and
Grp VTA DA neurons.
We found that Neurod6 mRNA was largely absent from
DA neurons projecting to regions outside of the NAc,
indicating a selective output of the Neurod6 DA neuron
population (Fig. 2H,I). By contrast, Grp DA neurons rep-
resented a substantial percentage (47.3%  2.4%) of DA
neurons projecting to the dorsomedial striatum (DMS; Fig.
2D–G). 87.7%  2.5% of the DMS-projecting Grp-
positive neurons were located in the ventromedial portion
of the SNc (Fig. 2-1B), consistent with prior reports map-
ping dopaminergic projections to the DMS (Lerner et al.,
2015). These neurons lacked expression of Neurod6, as
essentially no DMS-projecting neurons were Neurod6-
positive (Fig. 2H,I). Taken together, these results indicate
that there are at least two populations of DA neurons that
express Grp: those located in the VTA that project primar-
ily to the medial NAc and those in the ventromedial SNc,
which project selectively to the DMS (Fig. 2-1B,C).
A recent study showed that Neurod6-expressing DA
neurons, labeled by a Cre reporter in NEX-Cre mice [Neu-
continued
Grp/Neurod6 (purple) DA neurons in the midbrain. C, High-magnification confocal images showing Th-positive VTA neurons
expressing Grp (blue circles), Neurod6 (red circles), Grp and Neurod6 (purple circles), or neither marker (white circles). D, Charts show
the distribution of Grp or Neurod6 neurons across different midbrain regions, expressed as a percentage of the total Grp or
Neurod6 population. Only DA neurons, defined by expression of Th mRNA, were included in the analysis, n  4377 cells quantified
from 8 mice (4 male and 4 female). E, Quantification of the number of Th DA neurons that coexpress Grp or Neurod6 in subregions
of the VTA and SNc. Bars represent mean  SEM, dots represent the values from individual mice, n  4377 Th cells quantified from
4 male and 4 female mice. Grp one-way ANOVA, p  0.0001; Tukey’s post hoc tests revealed significant (p  0.0001) differences for
each subpopulation compared to all others except the PBP versus SNc-V (p  0.9998). Neurod6 one-way ANOVA, p  0.0001;
Tukey’s post hoc tests revealed significant (p  0.0001) differences for each subpopulation compared to all others except the IF
versus PN/PIF (p  0.0842) and SNc-V versus SNc-D (p  0.9699). F, Venn diagrams display the extent of overlap between the Grp
and Neurod6-expressing DA neuron populations across four midbrain subregions. 1833 cells were quantified from 8 mice (4 male and
4 female). G, H, Graphs display the mean  SEM percentage of Grp (G) or Neurod6 (H) DA neurons in the VTA at 2, 8, and 16 wk.
Statistical comparisons were made with a one-way ANOVA with Tukey’s post hoc test; Grp 8 wk (34.9%) vs. 16 wk (36.9%), , p 
0.0316, Neurod6 2 wk (25.2%) vs. 16 wk (27.6%), , p  0.0201. Dots represent values from individual mice, n  2053–2324 cells
from 2 male and 2 female mice per time point. I, J, Graphs display the mean  SEM percentage of Grp (I) or Neurod6 (J) DA
neurons across subregions of the VTA and SNc in male (M) and female (F) mice. Unpaired t tests between males and females for each
region revealed no significant sex differences. Dots represents values from individual mice, n 3586 cells from 6 male mice and 3424
cells from 6 female mice. IF, interfascicular nucleus; PN/PIF, paranigral/parainterfascicular nuclei; PBP, parabrachial pigmented
nucleus; SNc-V, substantia nigra pars compacta-ventral portion; SNc-D, substantia nigra pars compacta-dorsal portion. See also Fig.
1-1.
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Figure 2. Projection targets of Grp or Neurod6 DA neurons. A, Schematic of retrobead injection sites in sagittal view. Numbers
correspond to the coronal section schematics below showing the eight projection target sites. mPFC, medial prefrontal cortex; DLS,
dorsolateral striatum; DMS, dorsomedial striatum; LSh, lateral shell; C, core; MSh, medial shell; LS, lateral septum; BLA, basolateral
amygdala. B, Image showing a green fluorescent retrobead injection into the nucleus accumbens (NAc) medial shell with DAPI
staining in blue. C, Image of the VTA showing fluorescent in situ hybridization (FISH) for Slc6a3 (DAT) mRNA (white), Neurod6 mRNA
(red), and green retrobeads from a NAc medial shell injection. D, Image showing a green retrobead injection into the dorsomedial
striatum (DMS) with DAPI staining in blue. E, FISH image of the midbrain showing Th mRNA (white), Grp mRNA (red), and green
retrobeads from a DMS injection. Insets boxes in C and E show higher-magnification images of the boxed regions. Red circles identify
Neurod6 (C) or Grp (E) neurons, green circles define bead-positive neurons, and yellow circles show bead-positive neurons
expressing Neurod6 (C) or Grp (E). White circles identify neurons expressing Th only. F, Quantification of the percentage of Th/bead
midbrain neurons that coexpressed Grp mRNA for each of the projection sites. Bars represent mean SEM, each dot represents one
mouse. G, Summary of the projection targets of Grp DA neurons expressed as a percentage of total bead/Grp/Th neurons. H,
Quantification of the percentage of DAT/bead midbrain neurons that coexpressed Neurod6 mRNA for each of the projection sites.
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rod6 was previously referred to as NEX (Goebbels et al.,
2006)], project to the lateral septum (Khan et al., 2017).
We found relatively few lateral septum-projecting neurons
in the midbrain, of which 37.4%  3.1% were non-
dopaminergic (92/252 cells from 4 mice). Of the DA neu-
rons projecting to the lateral septum, 17.0% 2.3% were
Grp and 24.0%  3.0% were Neurod6 (Fig. 2F,H).
Quantified as a percentage of total bead-labeled neurons,
2% of Grp or Neurod6 DA neurons projected to the
lateral septum (Fig. 2G,I). These results indicate that com-
pared to other brain regions, the lateral septum is not a
major target for Grp- or Neurod6-expressing DA neurons.
Neurod6 DA neurons have unique physiological
properties
DA neurons projecting to different target areas possess
distinct electrophysiological profiles (Lammel et al., 2008;
Margolis et al., 2008; Lerner et al., 2015). To investigate
whether Neurod6 expression defines a physiologically
distinct subclass of DA neurons, we used NEX-Cre
knock-in mice (Goebbels et al., 2006). We injected virus
expressing a Cre-dependent tdTomato reporter (AAV-
Flex-tdTomato) into the midbrain and found NEX-Cre DA
neurons along the ventromedial portion of the VTA (Fig.
3A), consistent with the expression pattern of Neurod6
mRNA. In agreement with our tracing data, we found that
tdTomato-labeled NEX-Cre neurons projected to the
NAc medial shell and core (Fig. 3B). To visualize NEX-
Cre neurons for physiology, we crossed NEX-Cre mice
to the Ai9 tdTomato Cre-reporter mouse line (Madisen
et al., 2010). We performed FISH for Neurod6 mRNA in
NEX-Cre;Ai9 mice (Fig. 3C) and found that 93.6% 1.2%
of tdTomato–positive DA neurons in the VTA coexpressed
Neurod6 (331/353 cells from 4 mice), making this a suit-
able model to use for targeted electrophysiology record-
ings. Consistent with the 77.5% of Neurod6 neurons that
coexpressed Grp, 73.7%  2.9% of the NEX-Cre;
tdTomato–positive VTA DA neurons expressed Grp (175/
232 cells from 4 mice). We did observe that not all Neu-
rod6 VTA DA neurons expressed tdTomato in the NEX-
Cre;Ai9 mice (30.4%  1.7% of Neurod6 DA neurons
were tdTomato-positive, 361/1092 cells from 4 mice). In
addition, a third of the tdTomato-positive midbrain neu-
rons were non-dopaminergic (36.9% 3.4% Th negative,
193/546 cells from 4 mice). This discrepancy may be due
to transient Cre expression in non-DA neurons during
development. These data suggest that NEX-Cre mice may
not be appropriate for studies requiring selective access
to the entire Neurod6 VTA DA subpopulation, but can be
used to target Neurod6 cells for whole-cell recordings in
which dopaminergic identity can be confirmed post hoc.
To determine if Neurod6-expressing neurons repre-
sent a functionally distinct cell class, we recorded from
tdTomato-labeled NEX-Cre neurons in the VTA and an-
alyzed their intrinsic membrane properties, action poten-
tial waveform, and response to hyperpolarizing current
injection (see Fig. 3-1 for a summary of the physiology
data including sample sizes). We confirmed that the NEX-
Cre neurons analyzed were dopaminergic by filling
patched neurons with neurobiotin and costaining for TH
(Fig. 3D,E). We found that NEX-Cre DA neurons had a
distinct electrophysiological signature compared to “clas-
sic” SNc DA neurons. Specifically, NEX-Cre DA neurons
exhibited a more depolarized membrane potential (Vm,
p  0.0075,p unpaired t test), had higher membrane re-
sistance (Rm, p  0.0001,q unpaired t test), and reduced
membrane capacitance (Cm, p  0.0001,r unpaired t test)
compared to SNc DA neurons (Fig. 3F–H). The action
potential height of NEX-Cre DA neurons was also signif-
icantly shorter (p 0.0001,s unpaired t test), and they had
a less pronounced afterhyperpolarization (AHP, p 
0.0002,t unpaired t test; Fig. 3I–K). Due to their high
membrane resistance, NEX-Cre DA neurons required
less negative current to hyperpolarize to –100 mV com-
pared to SNc DA neurons (–25 to –50 pA for NEX-Cre
neurons versus –150 pA for SNc neurons). NEX-Cre DA
neurons had a significantly smaller sag component, which
is indicative of smaller Ih (p 0.0001,
u unpaired t test, Fig.
3L–N) and less rebound depolarization (p  0.0001,v
unpaired t test, Fig. 3L,M,O). The noncanonical electro-
physiological characteristics of NEX-Cre neurons are
consistent with those reported for NAc medial shell-
projecting DA neurons (Lammel et al., 2008), suggesting
that Neurod6 is a useful marker for this VTA subpopula-
tion.
Neurod6-lacking VTA DA neurons show increased
susceptibility to degeneration in a 6-OHDA mouse
model
In addition to their anatomic location, projection targets,
and physiology, vulnerability to degeneration is a key
feature of DA neurons that differs by subtype. Previous in
vitro studies have implicated both Neurod6 and Grp as
being potentially neuroprotective (Chung et al., 2005; Uit-
tenbogaard and Chiaramello, 2005; Uittenbogaard et al.,
2010; Baxter et al., 2012). In mice, expression of Neurod6
and the related transcription factor Neurod1 are important
for survival of DA neurons during development (Khan
et al., 2017). Grp-expressing cells have been observed in
postmortem tissue from PD patients, suggesting that Grp
expression may be related to cell survival (Viereckel et al.,
2016). We therefore investigated the sensitivity of Neu-
rod6 and/or Grp-expressing VTA DA neurons to degener-
ation in a mouse model of PD. To do this, we injected the
dopaminergic toxin 6-hydroxydopamine (6-OHDA) unilat-
erally into the medial forebrain bundle of adult (P120)
continued
Bars represent mean  SEM, each dot represents one mouse. I, Summary of the projection targets of Neurod6 DA neurons
expressed as a percentage of total bead/Neurod6/DAT neurons. For panels F–I: NAc MSh n 850 cells from 2 male and 2 female
mice, NAc Core n  858 cells from 2 males and 2 females, NAc LSh n  1215 cells from 3 males and 1–2 females, DMS n  637
cells from 3 males and 2 females, DLS n  1038 cells from 2–4 males and 2–3 females, mPFC n  211 cells from 3–4 males and
1 female, BLA n  297 cells from 3 males, and LS n  345 cells from 2 males and 4 females. See also Fig. 2-1.
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Figure 3. Neurod6-expressing DA neurons have noncanonical physiological properties. A, Cre-dependent tdTomato-expressing virus
(AAV-Flex-tdTomato) was injected unilaterally into the VTA of a NEX-Cre mouse. Right panel shows tdTomato-labeled NEX-Cre
neurons in the ventromedial VTA. Tyrosine hydroxylase (TH) staining is in blue. B, Confocal image of the nucleus accumbens (NAc)
showing tdTomato-labeled projections from midbrain NEX-Cre neurons. MSh, medial shell; LSh, lateral shell. C, Confocal images
of VTA neurons from NEX-Cre;Ai9 mice with fluorescent in situ hybridization (FISH) for tyrosine hydroxylase (Th) and Neurod6 mRNA.
The tdTomato Cre-reporter is expressed in NEX-Cre neurons. NEX-Cre/Neurod6 DA neurons are circled in red, NEX-Cre-/
Neurod6 DA neurons are circled in white. D, E, Left panels show representative recording sites of NEX-Cre VTA (D) and NEX-Cre-
SNc neurons (E). Circles show the locations of recorded DA neurons. Right panels show examples of recorded, neurobiotin-filled
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female mice (Thiele et al., 2012). 6-OHDA resulted in a
progressive, unilateral loss of DA neurons with a 96.0% 
0.6% reduction in SNc DA neurons and a 69.3  1.1%
loss of VTA DA neurons after 4 wk (Fig. 4A). We confirmed
DA axon denervation throughout the striatum in the
6-OHDA–injected hemisphere, with notable sparing of DA
projections to the NAc medial shell and core (Fig. 4B). DA
neuron loss led to unilateral motor impairment as mea-
sured by the cylinder test (p  0.0002,w one-way ANOVA
with Tukey’s post hoc test: saline paw vs. 6-OHDA paw
p  0.0163, saline paw vs. both paws p  0.0157,
6-OHDA paw vs. both paws p  0.0002, n  4 mice).
To determine how Grp- and Neurod6-expressing DA
neurons in the VTA responded to 6-OHDA (Fig. 4C–F), we
compared the reduction of Grp and/or Neurod6 VTA
DA neurons between the saline and 6-OHDA hemisphere
to all VTA DA neurons defined by Th expression (Fig. 4G).
For this analysis, we included only VTA DA neurons, as
essentially all SNc neurons (including Grp SNc neurons)
degenerated in the 6-OHDA–injected hemisphere (Fig.
4A,C,D). We found that 4 wk following 6-OHDA injection,
26.1%  2.7% of Grp/Neurod6 DA neurons survived,
which was similar to the percentage of total Th VTA
neurons surviving (30.7%  1.1%; p  0.0001,x paired
one-way ANOVA; p  0.3169, Tukey’s post hoc test; Fig.
4G). Notably, VTA DA neurons that expressed only Neu-
rod6 and not Grp (Grp-/Neurod6) were significantly
spared compared to the rest of VTA DA neurons, with
82.7%  4.2% of neurons surviving (p  0.0022, Tukey’s
post hoc test, Fig. 4G). By contrast, VTA DA neurons that
expressed Grp but not Neurod6 (Grp/Neurod6–) showed
slightly increased vulnerability compared to all VTA DA
neurons, with 21.7%  2.0% surviving (p  0.0246,
Tukey’s post hoc test, Fig. 4G). Therefore, the DA neuron
subpopulations marked by expression of Grp and/or Neu-
rod6 have different responses to 6-OHDA, and VTA neurons
lacking Neurod6 are more susceptible to degeneration.
An increase in the proportion of Neurod6 DA neurons
in the VTA following 6-OHDA could be due to selective
sparing of the Neurod6 cell population or from Neurod6
expression turning on in surviving neurons of other VTA
subpopulations. To attempt to distinguish these possibil-
ities, we performed FISH for another VTA DA neuron
subtype marker Lypd1 (La Manno et al., 2016).
Under normal conditions, Lypd1 was expressed almost
exclusively in the PBP subregion of the VTA as well as
throughout the SNc (Fig. 4D,F). Neurod6 was generally
not coexpressed in Lypd1 DA neurons (7.0%  1.6% of
Lypd1 DA neurons coexpressed Neurod6, Fig. 4D,F,H),
indicating that these markers define distinct cell popula-
tions. In response to 6-OHDA, we found that 20.4% 
1.3% of Lypd1/Neurod6- VTA DA neurons survived,
which was significantly lower than the total VTA DA pop-
ulation (p  0.0403, Tukey’s post hoc test, Fig. 4G). The
surviving Lypd1 VTA DA neurons did not turn on expres-
sion of Neurod6, as the proportion of Neurod6/Lypd1
VTA DA neurons remained low and was the same be-
tween the saline-injected and 6-OHDA–injected hemi-
spheres (p 0.8091,y paired t test, Fig. 4H). These results
suggest that the VTA DA subpopulation defined by Neu-
rod6 expression, which lacks Grp or Lypd1, is preferen-
tially spared in response to a neurotoxic challenge.
Discussion
Midbrain DA neurons are small in number but vast in
their behavioral influence (Björklund and Dunnett, 2007;
Roeper, 2013). As such, dopaminergic dysfunction is as-
sociated with numerous psychiatric and neurologic disor-
ders ranging from drug addiction to PD (Damier et al.,
1999; Alberico et al., 2015; Nutt et al., 2015). Recent
studies have revealed that the dopaminergic system is
heterogeneous at multiple levels from gene expression to
circuitry to physiology to behavior (Roeper, 2013; Morales
and Margolis, 2017). To tackle this heterogeneity, genetic
markers that define functional DA neuron subtypes are
needed. This would enable the generation of tools that
allow selective manipulation of dopaminergic subpopula-
tions. Here, we investigated two markers that we and
others have identified as labeling dopaminergic subpopu-
lations, Grp and Neurod6. We show that the combinatorial
expression of these genes defines the anatomic location,
projection target, physiology, and disease susceptibility of
DA neurons.
We found that Grp, which encodes the neuropeptide
gastrin-releasing peptide (Roesler and Schwartsmann,
2012), was expressed in a third of midbrain DA neurons,
of which more than half coexpressed Neurod6. These
Grp/Neurod6 neurons resided in the VTA and projected
to the medial portions of the NAc. This is consistent with
prior reports showing that Grp is expressed in a subpop-
ulation of VTA DA neurons that shows overlap with
Neurod6-expressing neurons (Chung et al., 2005; Greene
et al., 2005; Poulin et al., 2014; La Manno et al., 2016;
Viereckel et al., 2016). The fact that these neurons project
to the NAc corroborates a projection-specific translational
profiling study reporting that ribosome-bound Grp mRNA
was enriched in the population of VTA DA neurons pro-
jecting to the NAc (Ekstrand et al., 2014). Notably, we also
identified a previously undiscovered population of Grp
DA neurons that lack Neurod6, which were located in the
continued
neurons positive for TH. F–I, Graphs display the mean  SEM membrane potential (F, Vm, , p  0.0075), membrane resistance (G,
Rm, , p  0.0001), capacitance (H, Cm, , p  0.0001), and afterhyperpolarization (I, AHP, , p  0.0002) for NEX-Cre and
SNc neurons. J, K, Representative action potential traces and phase plots (mVms	1/mV) from a NEX-Cre (J) and SNc (K) neuron.
L, M, Representative responses to a 500 ms negative current step from a NEX-Cre (–25 pA, L) and SNc (–150 pA, M) neuron. N,
Quantification of the mean  SEM sag component in NEX-Cre and SNc neurons (, p  0.0001). O, Quantification of the mean 
SEM rebound depolarization from neurons hyperpolarized to –100  7 mV (, p  0.0001). An unpaired t test was used for all
comparisons. For all panels, dots represent values from individual cells, NEX-Cre n  7 male and 7 female mice, NEX-Cre-/SNc n 
4 male mice and 1 female mouse. See Fig. 3-1 for a complete summary of the electrophysiology results.
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Figure 4. Neurod6-expression affects susceptibility to 6-OHDA–induced degeneration. A, Confocal image of a midbrain section
stained with a tyrosine hydroxylase (TH) antibody 4 wk after unilateral saline (left) or 6-OHDA (right) injection into the medial forebrain
bundle. B, Image of a striatal (Str) section showing loss of tdTomato axon terminals 4 wk following unilateral 6-OHDA injection in
a DATIRESCre;Ai9 mouse. NAc, nucleus accumbens. C, Schematic showing the location of DA neurons in the saline and 6-OHDA
injected hemispheres labeled with different markers by fluorescent in situ hybridization (FISH): blue circles are Grp, red circles are
Neurod6, and purple circles are Grp/Neurod6. D, Schematic showing the location of Lypd1 (green), Neurod6 (red), and
Lypd1/Neurod6 (yellow) DA neurons in the midbrain following saline and 6-OHDA injection. E, F, Confocal images of FISH for the
indicated markers. E, Images show Grp (blue circle), Neurod6 (red circles), and Grp/Neurod6 (purple circles) DA neurons in the
VTA following saline and 6-OHDA injection. F, Images show Lypd1 (green circles), Neurod6 (red circles), and Lypd1/Neurod6
(yellow circle) DA neurons in the VTA following saline and 6-OHDA injection. G, Box-and-whisker plots (min to max) show the
percentage of VTA DAT neurons expressing each set of markers in the 6-OHDA–injected hemisphere compared to the saline-injected
hemisphere. Dotted line represents the percentage of all VTA DA neurons (Th) surviving in the 6-OHDA hemisphere. Dots represent
data from individual mice, n  4 female mice. A paired one-way ANOVA with Dunnett’s multiple comparisons test was used to
compare each subpopulation to all Th VTA DA neurons (n  4376 saline and 1352 6-OHDA cells): Grp–/Neurod6 (n  184 saline
and 151 6-OHDA cells),  p  0.0022; Grp/Neurod6 (n  763 saline and 207 6-OHDA cells), p  0.3169; Grp/Neurod6– (n  749
saline and 165 6-OHDA cells),  p  0.0246; Lypd1/Neurod6– (n  1056 saline and 171 6-OHDA cells),  p  0.0313; Nd6 
Neurod6. H, Bar graphs display the percentage of Lypd1 VTA DA neurons that coexpress Neurod6 mRNA in the saline-injected (n
102/3750 cells) and 6-OHDA–injected (n  16/904 cells) hemispheres. Bars represent mean  SEM, dots represent the values from
individual mice, n  4 female mice; paired t test, n.s., not significant, p  0.8091.
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ventromedial portion of the SNc. These neurons sent
projections to the DMS with very little innervation of the
DLS. The anatomic location of these cells in the ventral
SNc is consistent with DA neurons that project to the
DMS, which have unique physiological and behavioral
properties compared to DLS-projecting DA neurons lo-
cated in the dorsal SNc (Lerner et al., 2015).
Neurod6 expression defined a smaller population of DA
neurons that were located in the ventromedial VTA, pro-
jected selectively to the NAc, and exhibited noncanonical
physiologic properties. While Neurod6 has previously been
identified as a VTA marker (Chung et al., 2005; La Manno
et al., 2016; Viereckel et al., 2016; Khan et al., 2017), our
study is the first to systematically map the projection sites
of these cells, revealing a strong medial shell NAc projec-
tion with very little output to other DA target regions. This
medial shell NAc projection is consistent with the physi-
ology of Neurod6 DA neurons, which showed unique
characteristics similar to those previously reported for
medial NAc-projecting DA neurons defined by retrograde
labeling (Lammel et al., 2008). Mesoaccumbens projections
are important for mediating reward-seeking behaviors (Yun
et al., 2004; Ikemoto, 2007; Lammel et al., 2011, 2014).
Therefore, our identification of Neurod6 as a marker for
this cell population enables future mechanistic investiga-
tions into how this DA subcircuit controls motivated be-
haviors, the dysfunction of which may be important for the
pathophysiology of psychiatric disorders such as drug
addiction.
It was previously reported that Neurod6 neurons proj-
ect to the lateral septum based on the axon projections of
NEX-Cre mice and fluorogold retrograde labeling (Khan
et al., 2017). However, projections from the VTA to the
lateral septum are relatively sparse compared to the stria-
tum and NAc (Beckstead et al., 1979; Swanson, 1982;
Beier et al., 2015). To investigate this further, we per-
formed retrobead injections into the dorsal and interme-
diate regions of the lateral septum and found that
relatively few VTA DA neurons projected to this area. The
lateral septum therefore represented only 2% of total
bead-labeled Neurod6 DA cells across all injection sites.
This indicates that under our conditions, the lateral sep-
tum was not a primary projection site of Neurod6 DA
neurons. One possible reason for the discrepancy is that
the Khan et al. (2017) study relied exclusively on the
NEX-Cre mouse line, as opposed to endogenous Neu-
rod6 expression as done here. We found that a substan-
tial proportion (37%) of the VTA neurons labeled in NEX-
Cre mice are non-dopaminergic and that many of the VTA
neurons projecting to the lateral septum are also non-
dopaminergic (37%), which may have contributed to the
differing results.
A defining feature of DA neurons is their susceptibility or
resilience to degeneration in the context of PD (Damier
et al., 1999; Alberico et al., 2015). As such, significant
effort has been made to identify the molecules that de-
termine vulnerability, as this has clear clinical importance
(Brichta and Greengard, 2014). Interestingly, in addition to
being genes that define specific DA neuron subtypes,
both Neurod6 and Grp have been shown to confer neu-
roprotection in cell culture models (Chung et al., 2005;
Uittenbogaard and Chiaramello, 2005; Uittenbogaard et al.,
2010; Baxter et al., 2012). To determine if the neuronal
populations defined by Neurod6 and/or Grp are preferen-
tially spared in the context of PD, we performed unilateral
6-OHDA injections and compared the relative abundance
of these markers in the 6-OHDA versus control hemi-
sphere. We found that expression of either of these genes
alone was not sufficient to confer neuroprotection, as
Grp neurons in the SNc degenerated completely and
Grp neurons in the VTA showed either similar (Grp/
Neurod6) or greater (Grp/Neurod6-) susceptibility rela-
tive to all VTA DA neurons. Notably, we did find that the
small population of Neurod6 VTA DA neurons that lack
Grp was significantly spared compared to neighboring DA
neurons. This finding is consistent with a potential neuro-
protective effect of Neurod6 but indicates that other fac-
tors are likely involved, since Neurod6 VTA DA neurons
that coexpressed Grp were not preferentially spared. To-
gether, these results refine our understanding of the ge-
netic factors contributing to vulnerable and spared DA cell
types and suggest that the combinatorial expression of
genes in a given cell population is important for defining
vulnerability.
In summary, our work provides in-depth characteriza-
tion of Neurod6 and Grp expression in the midbrain and
reveals previously unappreciated complexity in how these
markers define specific DA subpopulations. Our results
provide new insights into the genetic and functional het-
erogeneity of the DA system, which is just beginning to be
unraveled. Future studies can use this information to de-
sign intersectional genetic tools based on the expression
of two or more genes that will allow access to specific
dopaminergic subpopulations. These types of tools rep-
resent powerful approaches to dissecting the complex
ways in which the DA system contributes to behavior and
disease.
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